Tazcus-LN Tablet
Marketer
Sycus Lifesciences Pvt Ltd.
Salt Composition
Cilnidipine (10mg) + Telmisartan (40mg)
Overview Tazcus-LN Tablet
Each Tazcus-LN Tablet combines two active ingredients, both working synergistically to manage hypertension. It achieves this by vasodilation, easing the heart's workload and improving circulation. This reduces the likelihood of cardiovascular events such as stroke or myocardial infarction. Tazcus-LN Tablets can be administered with or without food, but consistent daily dosing at the prescribed time is crucial for efficacy. Dosage is individualized based on your response and health status. Continued use, even during periods of well-being, is vital to maintain blood pressure control and mitigate long-term risks. Lifestyle modifications, including regular exercise, smoking cessation, and a low-sodium, low-fat diet, complement the medication's effects. Potential side effects include peripheral edema, headache, somnolence, vertigo, fatigue, altered taste perception, and gastrointestinal upset. Dizziness may impair alertness; avoid driving or demanding tasks until its effects are known. Report persistent or bothersome side effects to your physician. Prior to commencing treatment, inform your doctor of any pre-existing renal or hepatic impairment, or significant dehydration. Pregnant or lactating individuals require medical consultation before use. Regular blood pressure monitoring and potential kidney function tests are necessary during Tazcus-LN therapy.
Uses of Tazcus-LN Tablet
Managing Elevated Blood Pressure
Major Benefits of Tazcus-LN Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Tazcus-LN Tablets can be administered with or without food, however, consistent timing is recommended.
Common Side effects of Tazcus-LN Tablet:
- Ankle swelling
- Headache
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Dizziness
- Tiredness
- Palpitations
- Upset stomach
- Increased potassium level in blood
- Cardiogenic shock
How to use Tazcus-LN Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Tazcus-LN Tablets can be consumed with or without food, although consistent timing is recommended.
How Tazcus-LN Tablet works:
Tazcus-LN tablets contain cilnidipine, a calcium channel blocker, and telmisartan, an angiotensin receptor blocker. This dual-action formulation effectively reduces blood pressure by promoting vasodilation and improving cardiac output.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol while taking Tazcus-LN Tablets.
PregnancyCONSULT YOUR DOCTOR
Using Tazcus-LN Tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Tazcus-LN Tablet use while breastfeeding is currently lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving should be avoided if you experience drowsiness, dizziness, visual disturbances, or reduced awareness after taking Tazcus-LN Tablet. These side effects are possible.
KidneyCONSULT YOUR DOCTOR
Data on Tazcus-LN Tablet use in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Tazcus-LN Tablets cautiously, potentially requiring a modified dosage. Physician consultation is advised. Tazcus-LN Tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Tazcus-LN Tablet :
Should you forget a Tazcus-LN Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Tazcus-LN Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |



